World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
38092
World Ranking
9966
National Ranking
964

Overview

Dave Singh is affiliated with the University of Manchester in the United Kingdom and works extensively in the field of Medicine, with a strong focus on Pulmonary and Respiratory Medicine. Their research also spans related subfields such as Physiology, Immunology, Emergency Medical Services, and Infectious Diseases.

The primary topics that characterize Dave Singh's scientific work include:

  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Asthma and respiratory diseases
  • Respiratory Support and Mechanisms
  • Respiratory and Cough-Related Research
  • Inhalation and Respiratory Drug Delivery
  • Pediatric health and respiratory diseases
  • IL-33, ST2, and ILC Pathways

Singh has contributed frequently to several well-known publication venues, including:

  • American Journal of Respiratory and Critical Care Medicine
  • Respiratory Research
  • European Respiratory Journal
  • CHEST Journal
  • International Journal of COPD

The scientist has collaborated regularly with other researchers in the field. Frequent co-authors of Singh's work include Alberto Papi, Fernando J. Martínez, David Halpin, MeiLan K. Han, and Klaus F. Rabe.

Notable recent papers associated with Dave Singh include:

  • Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary, 2023, European Respiratory Journal
  • Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease, 2020, American Journal of Respiratory and Critical Care Medicine
  • Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary, 2023, American Journal of Respiratory and Critical Care Medicine
  • Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD, 2020, New England Journal of Medicine
  • Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial, 2020, The Lancet Respiratory Medicine

Best Publications

  • Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary

    Claus F. Vogelmeier;Gerard J. Criner;Fernando J. Martinez;Antonio Anzueto

  • Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.

    Dave Singh;Alvar Agusti;Antonio Anzueto;Peter J. Barnes

  • Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

    David A. Lipson;Frank Barnhart;Noushin Brealey;Jean Brooks

  • The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines

    Julie E. Gibbs;John Blaikley;Stephen Beesley;Laura Matthews

  • Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease

    David M G Halpin;Gerard J Criner;Alberto Papi;Dave Singh

  • Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.

    Alberto Papi;Jørgen Vestbo;Leonardo Fabbri;Leonardo Fabbri;Massimo Corradi

  • Blood Eosinophils: A Biomarker of Response to Extrafine Beclomethasone/Formoterol in Chronic Obstructive Pulmonary Disease

    Salman H. Siddiqui;Alessandro Guasconi;Jørgen Vestbo;Paul Jones

  • Eosinophilic inflammation in COPD: prevalence and clinical characteristics

    Dave Singh;Umme Kolsum;Chris E. Brightling;Nicholas Locantore

  • Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

    Dave Singh;Alberto Papi;Massimo Corradi;Ilona Pavlišová

  • Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial.

    Jørgen Vestbo;Jørgen Vestbo;Alberto Papi;Massimo Corradi;Viktor Blazhko

  • Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.

    Phillip D Monk;Richard J Marsden;Victoria J Tear;Jody Brookes

  • Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD

    Klaus F. Rabe;Fernando J. Martinez;Gary T. Ferguson;Chen Wang

  • Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS) : baseline data from a prospective cohort study

    Dirkje S Postma;Chris Brightling;Simonetta Baldi;Maarten Van den Berge

  • Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD

    Claus F. Vogelmeier;Gerard J. Criner;Fernando J. Martinez;Antonio R Anzueto

  • Benralizumab for the Prevention of COPD Exacerbations

    Gerard J. Criner;Bartolome R. Celli;Christopher E. Brightling;Alvar Agusti

  • Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.

    David M.G. Halpin;Dave Singh;Ruth M. Hadfield

  • The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial.

    Ratko Djukanović;Tim Harrison;Sebastian L. Johnston;Flic Gabbay

  • Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management

    Prescott G Woodruff;Alvar Agusti;Nicolas Roche;Dave Singh

  • Superiority of “triple” therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD

    Dave Singh;Jean Brooks;Gerry Hagan;Anthony Cahn

  • Efficacy and safety of twice-daily aclidinium bromide in COPD patients: The ATTAIN study

    Paul W Jones;Dave Singh;Eric D Bateman;Alvar Agusti

Frequent Co-Authors

Jørgen Vestbo
Jørgen Vestbo University of Manchester
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Peter Lange
Peter Lange University of Copenhagen
Alberto Papi
Alberto Papi University of Ferrara
Mark T. Dransfield
Mark T. Dransfield University of Alabama at Birmingham
Christopher E. Brightling
Christopher E. Brightling University of Leicester
David A. Lomas
David A. Lomas University College London
Jadwiga A. Wedzicha
Jadwiga A. Wedzicha Imperial College London
MeiLan K. Han
MeiLan K. Han University of Michigan–Ann Arbor
Gerard J. Criner
Gerard J. Criner Temple University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in Medicine, online nursing and healthcare degrees offer flexible options to start or advance your career. Many reputable universities now offer nurse practitioner programs online, allowing you to step into advanced clinical roles while studying at your own pace.

For those with a non-nursing bachelor’s degree, cheapest online accelerated bsn programs can provide a faster route to becoming a registered nurse. These accelerated tracks combine rigorous coursework with practical clinical experience in a shorter time-frame.

Registered nurses (RNs) can further their careers with rn to bsn online programs, which are designed for working professionals. These programs help nurses acquire advanced skills, qualify for higher positions, and potentially increase earnings.

For future educators or leaders in healthcare, online nursing phd programs provide the opportunity to influence practice, policy, and research at the highest academic level—all online.

Best Scientists Citing Dave Singh

Trending Scientists